OA10286A - Inhibiting photodecomposition of 3-substituted-2-oxindoles - Google Patents

Inhibiting photodecomposition of 3-substituted-2-oxindoles Download PDF

Info

Publication number
OA10286A
OA10286A OA60821A OA60821A OA10286A OA 10286 A OA10286 A OA 10286A OA 60821 A OA60821 A OA 60821A OA 60821 A OA60821 A OA 60821A OA 10286 A OA10286 A OA 10286A
Authority
OA
OAPI
Prior art keywords
red
yellow
light
lake
dye
Prior art date
Application number
OA60821A
Other languages
English (en)
Inventor
Newlin Williard C Jr
Sharon M Laughlin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of OA10286A publication Critical patent/OA10286A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883Capsule finishing, e.g. dyeing, aromatising, polishing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polymerisation Methods In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA60821A 1995-04-24 1996-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles OA10286A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (fr) 1995-04-24 1995-04-24 Inhibition de la photodecomposition des 2-oxindoles-3-substitues

Publications (1)

Publication Number Publication Date
OA10286A true OA10286A (en) 1997-09-19

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60821A OA10286A (en) 1995-04-24 1996-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Country Status (30)

Country Link
EP (1) EP0827399A1 (fr)
JP (1) JPH10506635A (fr)
KR (1) KR100189585B1 (fr)
CN (1) CN1053667C (fr)
AP (1) AP607A (fr)
AR (1) AR002728A1 (fr)
AU (1) AU692378B2 (fr)
BG (1) BG100531A (fr)
BR (1) BR9602024A (fr)
CO (1) CO4700418A1 (fr)
FI (1) FI973988A0 (fr)
HR (1) HRP960194A2 (fr)
HU (1) HU216544B (fr)
IL (1) IL117969A0 (fr)
IS (1) IS4339A (fr)
MA (1) MA23848A1 (fr)
NO (1) NO961622L (fr)
NZ (1) NZ286432A (fr)
OA (1) OA10286A (fr)
PE (1) PE34397A1 (fr)
RO (1) RO113305B1 (fr)
RU (1) RU2109510C1 (fr)
SG (1) SG64924A1 (fr)
SI (1) SI9600133A (fr)
SK (1) SK51296A3 (fr)
TR (1) TR199600300A2 (fr)
UA (1) UA42739C2 (fr)
WO (1) WO1996033701A1 (fr)
YU (1) YU25096A (fr)
ZA (1) ZA963210B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019132959A1 (fr) 2017-12-29 2019-07-04 Kraft Foods Group Brands Llc Stabilité oxydative améliorée d'émulsions huile dans eau à l'aide de stabilisants naturels

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
AP607A (en) 1997-08-27
UA42739C2 (uk) 2001-11-15
SK51296A3 (en) 1997-04-09
FI973988A (fi) 1997-10-17
HRP960194A2 (en) 1998-02-28
IL117969A0 (en) 1996-08-04
WO1996033701A1 (fr) 1996-10-31
NO961622D0 (no) 1996-04-23
BR9602024A (pt) 1998-10-06
EP0827399A1 (fr) 1998-03-11
NZ286432A (en) 1998-05-27
RU2109510C1 (ru) 1998-04-27
NO961622L (no) 1996-10-25
RO113305B1 (ro) 1998-06-30
AR002728A1 (es) 1998-04-29
HU9601057D0 (en) 1996-06-28
IS4339A (is) 1996-10-25
AP9600787A0 (en) 1996-04-30
SI9600133A (en) 1996-10-31
AU692378B2 (en) 1998-06-04
HUP9601057A2 (en) 1997-04-28
CN1139110A (zh) 1997-01-01
MA23848A1 (fr) 1996-12-31
CO4700418A1 (es) 1998-12-29
AU5085196A (en) 1996-11-07
KR960037656A (ko) 1996-11-19
FI973988A0 (fi) 1997-10-17
TR199600300A2 (tr) 1996-11-21
CN1053667C (zh) 2000-06-21
BG100531A (en) 1997-06-30
SG64924A1 (en) 1999-05-25
JPH10506635A (ja) 1998-06-30
YU25096A (sh) 1998-08-14
HUP9601057A3 (en) 1997-05-28
ZA963210B (en) 1997-10-23
HU216544B (hu) 1999-07-28
PE34397A1 (es) 1997-09-29
KR100189585B1 (ko) 1999-06-01

Similar Documents

Publication Publication Date Title
US5331000A (en) Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
KR950703539A (ko) 당뇨병 합병증 치료용 치환된 피리미딘(substituted pyrimidines for control or diabetic complications)
FR2684876A1 (fr) Compositions pharmaceutiques stabilisees comprenant un compose inhibiteur de la hmg-coa reductase et procede pour leur preparation.
JO2239B1 (en) Method for preparing benzothophen derivatives
SK282183B6 (sk) Farmaceutický prostriedok
SK7899A3 (en) Antithrombotic and antiatherogenic pharmaceutical composition including a thienopyridine derivative and an hmg-coa-reductase inhibitor
CA2003478A1 (fr) Combinaison d'un inhibiteur de hmg coa reductase et d'un autre type d'agent reducteur du cholesterol serique et methode de reduction du cholesterol serique par l'emploi de ladite combinaison
CA1069441A (fr) Produit pharmaceutique contenant de la 2,1,3-benzothiazole
OA10286A (en) Inhibiting photodecomposition of 3-substituted-2-oxindoles
US3519717A (en) Novel method for lowering high blood pressure and compositions therefor
CO4410322A1 (es) Nuevos compuestos de carboxamida, sus sales farmaceuticamente aceptables y composiciones farmaceuticas que los contienen
CA2216931A1 (fr) Inhibition de la photodecomposition des 2-oxindoles-3-substitues
US4188393A (en) Treating spastic conditions or relaxing muscles
EA199900510A1 (ru) Инъекционное лекарственное средство "цитофлавин", обладающее цитопротекторным действием
US4333945A (en) Thiazoline and imidazoline derivatives useful as minor tranquilizers
NO932382L (no) Heterocykliske forbindelser
EP0444546A1 (fr) Dérivés de l'hydantoine pour l'utilisation comme agents hypoglycémiques et/ou hypolipidémiques
US3592905A (en) Therapeutic methods
NL193821C (nl) Farmaceutisch preparaat.
US4145421A (en) Treating spastic conditions
US4795759A (en) Use of dibenz(CD,F)indoles
AU620658B2 (en) Memory-enhancing compositions containing dioxopiperidine derivatives
BE881717A (fr) Medicament a base d'un compose heterocyclique bicyclique condense
CA2143544A1 (fr) Agents pharmaceutiques pour le traitement des lesions myocardiques causees par une ischemie et par des cytokines
RU96108120A (ru) Способ ингибирования, таблетка и капсула